DAZ-304: A Long-term Extension Study of Dazodalibep in Participants with SS
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Amgen, Inc.
Start Date
June 1, 2025
End Date
May 31, 2030
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Amgen, Inc.
Start Date
June 1, 2025
End Date
May 31, 2030